Europe Gives Go Ahead To Market Ebola Vaccine
Sumaira FH Published November 11, 2019 | 10:27 PM
The European Union authorised the marketing of a vaccine against Ebola on Monday, permitting the first wider commercial use of a protection that has helped stem an outbreak in DR Congo
The European Commission announced that, after a trial by the European Medicines Agency (EMA), it would allow US pharmaceutical giant Merck to bring the drug to market in the bloc as "Ervebo".
Previously, the UN's World Health Organization had welcomed the advice of the EMA in favour of Ervebo as a "major milestone" -- and more vaccines from other manufacturers are to be tested soon.
"Finding a vaccine as soon as possible against this terrible virus has been a priority for the international community ever since Ebola hit West Africa five years ago," said EU health commissioner Vytenis Andriukaitis "Today's decision is therefore a major step forward in saving lives in Africa and beyond." Since the start of the latest outbreak in the Democratic Republic of Congo, which has claimed some 2,150 lives since August 2018, more than 236,000 people have received the vaccine, known in the lab as rVSV-ZEBOV-GP.
They included more than 60,000 health workers. Merck's vaccine was being administered under an exceptional procedure, granting permission to use non-licensed drugs in emergency cases.
It was tested in about 16,000 people in clinical studies in Africa, Europe and the United States, and proved to be effective. Additional data is being collected.
Earlier this month, DR Congo medical officials said a second vaccine, Ad26-ZEBOV-GP produced by Johnson & Johnson, will also be introduced from November. And eight vaccines are undergoing clinical evaluation.
This is the eighth epidemic of the deadly haemorrhagic fever on Congolese soil since the disease was first identified in the country, then called Zaire, in 1976.
It is the second most deadly outbreak since around 11,000 people died in Guinea, Liberia and Sierra Leone between 2013 and 2016.
Related Topics
Recent Stories
Pakistan, China agree to promote cooperation in areas of information, culture
USCIRF’s report as faulty, non-reflective of ground realities in Pakistan: FO
TECNO answers to his Fans!! Price Drop to 55K?
Edotco Delegation Visits PTA
Qatar’s MoS for Foreign Affairs arrives in Islamabad
Seven labourers from Punjab shot dead in Gwadar
Nation will never forget criminals of 9th May who attacked state for politics: P ..
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 9 May 2024
Today Gold Rate in Pakistan 09 May 2024
IHC adjourns PTI founder, Qureshi's appeal till Thursday
CDWP recommends 3 projects to ECNEC for approval
Tarar assures APNS to resolve issues of newspaper industry
More Stories From Health
-
Anti- measles drive to start from May 20
20 hours ago -
229 diseases directly linked to obesity: Experts
2 days ago -
Health authorities asked for action against alleged illegal tenders at Services Hospital
6 days ago -
FDA officials urged to resolve peoples’ issues
6 days ago -
Health department confirms 2 deaths due to measles
7 days ago -
Vaccines save at least 154 million lives in 50 years: WHO
15 days ago
-
UHS to issue MBBS degrees within three months after final result
15 days ago -
Rawalpindi woman gives birth to six babies
20 days ago -
DC calls for intensive anti-polio drive in ICT
21 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
22 days ago -
Six in a family with heart on the 'right side'
22 days ago -
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
22 days ago